JP2014530873A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530873A5 JP2014530873A5 JP2014537297A JP2014537297A JP2014530873A5 JP 2014530873 A5 JP2014530873 A5 JP 2014530873A5 JP 2014537297 A JP2014537297 A JP 2014537297A JP 2014537297 A JP2014537297 A JP 2014537297A JP 2014530873 A5 JP2014530873 A5 JP 2014530873A5
- Authority
- JP
- Japan
- Prior art keywords
- collagenase
- injection
- efp
- administered
- affected area
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108060005980 Collagenase Proteins 0.000 claims 48
- 102000029816 Collagenase Human genes 0.000 claims 48
- 229960002424 collagenase Drugs 0.000 claims 48
- 238000002347 injection Methods 0.000 claims 11
- 239000007924 injection Substances 0.000 claims 11
- 238000010254 subcutaneous injection Methods 0.000 claims 8
- 239000007929 subcutaneous injection Substances 0.000 claims 8
- YRQNKMKHABXEJZ-UVQQGXFZSA-N chembl176323 Chemical compound C1C[C@]2(C)[C@@]3(C)CC(N=C4C[C@]5(C)CCC6[C@]7(C)CC[C@@H]([C@]7(CC[C@]6(C)[C@@]5(C)CC4=N4)C)CCCCCCCC)=C4C[C@]3(C)CCC2[C@]2(C)CC[C@H](CCCCCCCC)[C@]21C YRQNKMKHABXEJZ-UVQQGXFZSA-N 0.000 claims 2
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 241000193159 Hathewaya histolytica Species 0.000 claims 1
- 108010013295 Microbial collagenase Proteins 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549863P | 2011-10-21 | 2011-10-21 | |
| US61/549,863 | 2011-10-21 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017183076A Division JP2018027968A (ja) | 2011-10-21 | 2017-09-22 | Ｅｆｐの治療または低減方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530873A JP2014530873A (ja) | 2014-11-20 |
| JP2014530873A5 true JP2014530873A5 (cg-RX-API-DMAC7.html) | 2015-12-17 |
Family
ID=48141393
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537297A Pending JP2014530873A (ja) | 2011-10-21 | 2012-10-19 | Ｅｆｐの治療または低減方法 |
| JP2017183076A Pending JP2018027968A (ja) | 2011-10-21 | 2017-09-22 | Ｅｆｐの治療または低減方法 |
| JP2020103455A Pending JP2020158521A (ja) | 2011-10-21 | 2020-06-16 | Ｅｆｐの治療または低減方法 |
| JP2022098817A Pending JP2022123073A (ja) | 2011-10-21 | 2022-06-20 | Ｅｆｐの治療または低減方法 |
| JP2024098658A Pending JP2024123126A (ja) | 2011-10-21 | 2024-06-19 | Ｅｆｐの治療または低減方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017183076A Pending JP2018027968A (ja) | 2011-10-21 | 2017-09-22 | Ｅｆｐの治療または低減方法 |
| JP2020103455A Pending JP2020158521A (ja) | 2011-10-21 | 2020-06-16 | Ｅｆｐの治療または低減方法 |
| JP2022098817A Pending JP2022123073A (ja) | 2011-10-21 | 2022-06-20 | Ｅｆｐの治療または低減方法 |
| JP2024098658A Pending JP2024123126A (ja) | 2011-10-21 | 2024-06-19 | Ｅｆｐの治療または低減方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20140335072A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3581199B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP2014530873A (cg-RX-API-DMAC7.html) |
| AU (6) | AU2012325941A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112014009785B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2852942C (cg-RX-API-DMAC7.html) |
| DK (2) | DK2768523T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2953560T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3581199T3 (cg-RX-API-DMAC7.html) |
| HU (2) | HUE063599T2 (cg-RX-API-DMAC7.html) |
| MX (2) | MX2014004792A (cg-RX-API-DMAC7.html) |
| PL (1) | PL3581199T3 (cg-RX-API-DMAC7.html) |
| PT (2) | PT2768523T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013059619A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2802652T (pt) | 2012-01-12 | 2019-09-10 | Endo Global Ventures | Enzimas de clostridium histolyticum |
| EP2844276B1 (en) | 2012-05-01 | 2019-10-02 | Proteolease Ltd. | Methods for extracting a tooth |
| US9744138B2 (en) | 2013-03-15 | 2017-08-29 | Biospecifics Technologies Corp. | Treatment method and product for uterine fibroids using purified collagenase |
| CN103751102A (zh) * | 2014-01-15 | 2014-04-30 | 上海交通大学 | 一种胶原酶温敏水凝胶及其制备方法和应用 |
| DK3589204T3 (da) | 2017-03-01 | 2025-06-30 | Endo Operations Ltd | Apparat og fremgangsmåde til vurdering og behandling af cellulitis |
| AU2018244426B2 (en) | 2017-03-28 | 2024-09-19 | Endo Ventures Limited | Improved method of producing collagenase |
| WO2020021330A2 (en) * | 2018-07-12 | 2020-01-30 | Endo Global Aesthetics Limited | Injection techniques for the treatment of cellulite |
| WO2020021332A2 (en) * | 2018-07-12 | 2020-01-30 | Endo Global Aesthetics Limited | Injection techniques for the treatment of cellulite |
| WO2020023406A1 (en) * | 2018-07-23 | 2020-01-30 | Nc8, Inc. | Cellulite treatment system and methods |
| WO2020058755A1 (en) * | 2018-09-18 | 2020-03-26 | Endo Global Aesthetics Limited | Compositions and methods for treating cellulite |
| KR20210113271A (ko) * | 2019-01-06 | 2021-09-15 | 엔도 글로벌 에스테틱스 리미티드 | 콜라게나제 제형 및 이의 제조 방법 |
| AU2020366008B2 (en) | 2019-10-15 | 2025-08-28 | Biospecifics Technologies Corp. | Treatment of uterine fibroids using purified collagenase |
| US20210244642A1 (en) * | 2020-02-10 | 2021-08-12 | Simeon Wall, Jr. | Cellulite eradication methods |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4645668A (en) | 1983-08-04 | 1987-02-24 | Biospecifics, Nv | Method for the prevention and treatment of scars with enzymes |
| US4524065A (en) * | 1983-08-04 | 1985-06-18 | Bio-Specifics N.V. | Method for the prevention and treatment of scars with enzymes |
| US6958150B2 (en) * | 1994-12-15 | 2005-10-25 | Advance Biofactures Of Curacao, N.V. | Reduction of adipose tissue |
| ATE521355T1 (de) * | 2004-05-19 | 2011-09-15 | Los Angeles Biomed Res Inst | Verwendung eines detergens zur nicht- chirurgischen entfernung von fett |
| US20070224184A1 (en) * | 2006-02-22 | 2007-09-27 | The Research Foundation Of The State University Of New York | Method for treating cellulite |
| US7811560B2 (en) | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
| WO2007100590A2 (en) * | 2006-02-22 | 2007-09-07 | Auxilium Pharmaceuticals, Inc. | Methods for treating cellulite |
| WO2008101406A1 (en) * | 2007-02-14 | 2008-08-28 | Yolare Dermaceuticals, Llc | Modified mutant collagenase and it's use in fat melting and in scar reduction |
-
2012
- 2012-10-19 PT PT12842537T patent/PT2768523T/pt unknown
- 2012-10-19 JP JP2014537297A patent/JP2014530873A/ja active Pending
- 2012-10-19 PT PT191726439T patent/PT3581199T/pt unknown
- 2012-10-19 HU HUE19172643A patent/HUE063599T2/hu unknown
- 2012-10-19 EP EP19172643.9A patent/EP3581199B1/en active Active
- 2012-10-19 CA CA2852942A patent/CA2852942C/en active Active
- 2012-10-19 FI FIEP19172643.9T patent/FI3581199T3/fi active
- 2012-10-19 MX MX2014004792A patent/MX2014004792A/es active IP Right Grant
- 2012-10-19 DK DK12842537.8T patent/DK2768523T3/da active
- 2012-10-19 EP EP12842537.8A patent/EP2768523B1/en active Active
- 2012-10-19 BR BR112014009785-2A patent/BR112014009785B1/pt active IP Right Grant
- 2012-10-19 HU HUE12842537 patent/HUE044650T2/hu unknown
- 2012-10-19 PL PL19172643.9T patent/PL3581199T3/pl unknown
- 2012-10-19 WO PCT/US2012/061063 patent/WO2013059619A1/en not_active Ceased
- 2012-10-19 ES ES19172643T patent/ES2953560T3/es active Active
- 2012-10-19 ES ES12842537T patent/ES2741476T3/es active Active
- 2012-10-19 DK DK19172643.9T patent/DK3581199T3/da active
- 2012-10-19 MX MX2019007779A patent/MX392388B/es unknown
- 2012-10-19 AU AU2012325941A patent/AU2012325941A1/en not_active Abandoned
-
2014
- 2014-04-17 US US14/255,407 patent/US20140335072A1/en not_active Abandoned
-
2016
- 2016-03-31 AU AU2016202026A patent/AU2016202026A1/en not_active Abandoned
-
2017
- 2017-09-22 JP JP2017183076A patent/JP2018027968A/ja active Pending
- 2017-10-17 AU AU2017248451A patent/AU2017248451B2/en active Active
-
2020
- 2020-02-03 AU AU2020200763A patent/AU2020200763B2/en active Active
- 2020-06-16 JP JP2020103455A patent/JP2020158521A/ja active Pending
-
2022
- 2022-05-04 AU AU2022202987A patent/AU2022202987B2/en active Active
- 2022-06-20 JP JP2022098817A patent/JP2022123073A/ja active Pending
-
2024
- 2024-01-17 US US18/415,270 patent/US20240216485A1/en not_active Abandoned
- 2024-06-19 JP JP2024098658A patent/JP2024123126A/ja active Pending
-
2025
- 2025-06-16 AU AU2025204462A patent/AU2025204462A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530873A5 (cg-RX-API-DMAC7.html) | ||
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| JP2012067116A5 (cg-RX-API-DMAC7.html) | ||
| CY1113253T1 (el) | Δοσολογικο σχημα για τη θεραπευτικη αντιμετωπιση μιας τραυματικης εγκεφαλικης βλαβης με προγεστερονη | |
| HRP20170056T2 (hr) | Terapija male učestalosti glatiramer acetatom | |
| FI3998078T3 (fi) | Annoksensuurentamisentsyymikorvaushoito happaman sfingomyelinaasin puutoksen hoitamista varten | |
| JP2016204396A5 (cg-RX-API-DMAC7.html) | ||
| JP2020158521A5 (cg-RX-API-DMAC7.html) | ||
| FI3757126T3 (fi) | Menetelmä nivelreuman hoitamiseksi il-17-antagonistien avulla | |
| FI3581199T3 (fi) | Menetelmiä turvottavan fibroskleroottisen pannikulopatian hoitamiseksi tai vähentämiseksi | |
| EA201491285A1 (ru) | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты | |
| EA201270167A1 (ru) | Лекарственная форма глатирамера ацетата с уменьшенным объемом и способы введения | |
| JP2008044951A5 (cg-RX-API-DMAC7.html) | ||
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
| JP2013155188A5 (cg-RX-API-DMAC7.html) | ||
| JP2012522762A5 (cg-RX-API-DMAC7.html) | ||
| JP2016516016A5 (cg-RX-API-DMAC7.html) | ||
| RU2015103107A (ru) | Комбинированная композиция | |
| JP2012046489A5 (cg-RX-API-DMAC7.html) | ||
| JP2013541583A5 (cg-RX-API-DMAC7.html) | ||
| JP2013518124A5 (cg-RX-API-DMAC7.html) | ||
| NZ701205A (en) | Optimised subcutaneous therapeutic agents | |
| JP2015512927A5 (cg-RX-API-DMAC7.html) | ||
| JP2007119497A5 (cg-RX-API-DMAC7.html) |